A Phase I, Single-center, Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Trial Profile

A Phase I, Single-center, Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Sep 2010

At a glance

  • Drugs Atorvastatin; Fosdevirine; Rosuvastatin; Simvastatin
  • Indications Acute coronary syndromes; Alzheimer's disease; Atherosclerosis; Atrial fibrillation; Cardiovascular disorders; Diabetic cardiomyopathy; Diabetic foot ulcer; Heart failure; HIV-1 infections; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hyperlipoproteinaemias; Hypertriglyceridaemia; Low HDL cholesterol; Multiple sclerosis; Neurological disorders; Retinal vascular occlusion; Systemic lupus erythematosus
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 30 Aug 2010 Trial location (USA) added as reported by ClinicalTrials.gov.
    • 30 Aug 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top